Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
New York to require social media platforms to display mental health warnings - 2Vote in favor of the juice that you love for its medical advantages!
- 35 Movies That Leaving an Imprint with Inventive Innovation
- 4Vote in favor of Your #1 4\u00d74 SUVs
- 510 Fundamental Tips and Deceives to Lift Your Cell phone's Exhibition
- 'People We Meet on Vacation' is the 1st of many Emily Henry adaptations: What other books turned movies to look forward to
- Thousands of genomes reveal the wild wolf genes in most dogs’ DNA
- How did I get my own unique set of fingerprints?
- The 15 Most Motivating TED Discusses All Time
- How to watch 'Tell Me Lies' Season 3: Episode release times, streaming info and more
- 5 VIPs That Changed Style
- Flourishing as a Charitable Pioneer: Individual Encounters in Generosity
- Weight-loss pill approval set to accelerate food industry product overhauls
- With Obamacare premium hikes, more people opting for no coverage or cheaper plans
